Medtronic Estimates 2,400 Patients Eligible For Activa Dystonia Indication
This article was originally published in The Gray Sheet
Executive Summary
Medtronic may pursue full PMA approval of its Activa brain stimulation technology to treat dystonia, upon determining which patients react well to the therapy under a humanitarian device exemption
You may also be interested in...
Deep-Brain Stimulation Effects May Be Based On Structural Change – NEJM
Bilateral deep-brain stimulation (DBS) may effect structural changes in dystonia patients, thereby causing an alleviation of symptoms, according to a study in the Feb. 3 New England Journal of Medicine
Deep-Brain Stimulation Effects May Be Based On Structural Change – NEJM
Bilateral deep-brain stimulation (DBS) may effect structural changes in dystonia patients, thereby causing an alleviation of symptoms, according to a study in the Feb. 3 New England Journal of Medicine
Activa Alternative In Waiting? ANS Taps Deep Brain Stim, Spinal Drug Delivery
Advanced Neuromodulation Systems' deep-brain stimulation device to treat Parkinsonian tremor, nearing pivotal trials, should feature a smaller size and broader programming parameters than Medtronic's Activa DBS, according to the firm